XML 47 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of fair value of options granted

The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the year ended December 31, 2017, were as follows: 

 

    Employee     Non-Employee  
Expected volatility     71.6% to 83.7 %      N/A  
Expected dividend yield            N/A  
Expected term (in years)     3.0 to 3.5        N/A  
Risk-free interest rate      1.45% to 1.84 %      N/A  

  

The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the year ended December 31, 2018, were as follows: 

 

    Employee     Non-Employee  
Expected volatility     71.0% -79.8 %      N/A  
Expected dividend yield            N/A  
Expected term (in years)     3.0-3.5        N/A  
Risk-free interest rate     1.58%-2.89 %      N/A  
Schedule of stock option activity

The table summarizes the stock option activity, for both plans, for the periods indicated as follows: 

 

    Number of
Options
    Weighted
Average
Exercise
Price
Share
    Weighted
Average
Remaining
Contractual
Per Term
(years) 
    Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2016                            1,477,300     $ 1.61     5.8     $ 9,662  
Granted   258,500     $ 4.62     5.0     $ 34  
Exercised   (18,000 )   $ 0.50                
Forfeited   (1,000 )   $ 0.50                
Expired   (65,000 )   $ 10.22                
Outstanding at December 31, 2017   1,651,800     $ 1.67     3.7     $  
Granted   179,471     $ 1.53     4.4     $  
Exercised   (49,000 )   $ 0.50                
Forfeited   (50,500 )   $                
Expired   (10,600 )   $                
Outstanding at December 31, 2018   1,721,171     $ 1.57     4.0     $  
Exercisable at December 31, 2018   1,443,296     $ 1.56     3.5     $  

  

  (1) The aggregate intrinsic value on the table was calculated based on the difference between the estimated fair value of the Company’s stock and the exercise price of the underlying option. The estimated stock values used in the calculation was $0.59 and $0.72 per share for each of the years ended December 31, 2018 and 2017 respectively.
Schedule of stock-based compensation expense

The stock-based compensation expense was recorded as follows: 

 

    Years Ended December 31,  
    2018     2017  
Research and development   $ 106     $ 377  
General and administrative     3,306       3,338  
Total stock-based compensation expense   $ 3,412     $ 3,715  
Schedule of summarizes restricted stock unit activity

The following table summarizes restricted stock unit activity for the years ended December 31, 2017 and 2016: 

 

  Number of
 Units
    Weighted Average
Grant Date Fair
Value Per Units
 
Outstanding as of December 31, 2016 455,430     $ 0.76  
Granted  117,885 (1)   $ 6.95  
Vested (282,344 )   $ 1.75  
Forfeited          (3,086   $  
Outstanding as of December 31, 2017 287,885     $ 1.86  
Granted  75,732 (2)   $ 1.62  
Vested (223,795 )   $ 2.56  
Forfeited          (3,577   $ 6.99  
Outstanding as of December 31, 2018 136,345     $ 0.98  

  

  (1) 40,000 restricted stock units were granted on March 27, 2017 with a weighted average grant date fair value of $8.35, 17,885 restricted stock units were granted on May 19, 2017 with a weighted average grant date fair value of $6.99 and 60,000 restricted stock units were granted on June 19, 2017 with a weighted average grant date fair value of $6.00.

  

  (2) 12,820 restricted stock units were granted on June 12, 2017 with a weighted average grant date fair value of $0.65 and 62,912 restricted stock units were granted on June 12, 2018 with a weighted average grant date fair value of $1.82